|Bid||0.0000 x N/A|
|Ask||0.0000 x N/A|
|Day's range||1.1800 - 1.1850|
|52-week range||1.1800 - 1.1850|
|Beta (5Y monthly)||1.39|
|PE ratio (TTM)||N/A|
|Earnings date||29 Jul 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Abeona Therapeutics (ABEO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Abeona Therapeutics (ABEO) delivered earnings and revenue surprises of -88.89% and -45.95%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Abeona Therapeutics Inc. ( NASDAQ:ABEO ) shareholders will doubtless be very grateful to see the share price up 48% in...